Parallel Industries Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EAPH research report →
Price Chart
About the company
Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions.
- CEO
- Evan Karras
- IPO
- 1999
- Employees
- 6
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on EAPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $26.90K
- P/E
- -0.20
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 2784280.82
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.70%
- ROIC
- -1.97%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0-100.0%
- Op Income
- $-189,000
- Net Income
- $-189,000+41.5%
- EPS
- $-0.00+50.0%
- OCF Growth
- -136.9%
- FCF Growth
- -142.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.88
- RSI (14)
- 50
- Avg Volume
- 163.69K
No earnings-call transcripts are available for EAPH yet.
- Free Float
- 92.0%
- Shares Outstanding
- 1.34B
- Float Shares
- 1.24B
of shares held by institutions
1 13F filers
Our EAPH coverage
Recent articles, reports, and earnings notes.
No research on EAPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EAPH report →